Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-year follow-up study of total glucosides of peony in primary Sjogren's syndrome
ChiCTR1900022781Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- May 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of total glucosides of paeony in Sjögren's syndrome (SS) (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: European Alliance of Associations for Rheumatology Sjogren's Syndrome Patient Reported Index. Started May 2019; status: recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on ChiCTR1900022781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022781.